Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers
Inappropriate prescribing is a rising threat to the health of Medicare beneficiaries and a drain on Medicare’s finances. In this study we used a randomized controlled trial approach to evaluate a low-cost, light-touch intervention aimed at reducing the inappropriate provision of Schedule II controll...
Main Authors: | Sacarny, A., Yokum, D., Agrawal, S., Finkelstein, Amy |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Economics |
Format: | Article |
Language: | en_US |
Published: |
Project Hope
2016
|
Online Access: | http://hdl.handle.net/1721.1/105912 https://orcid.org/0000-0002-9941-6684 |
Similar Items
-
Are clinicians overdiagnosing strep throat and overprescribing antibiotics?
by: Kennedy A. Sabharwal, et al.
Published: (2023-11-01) -
Reducing Opioid Overprescribing through Procedure-specific Prescribing Guidelines
by: Kevin K. Zhang, BA, et al.
Published: (2023-01-01) -
The National Overprescribing Review for England - another step forward?
by: Treadwell, J
Published: (2021) -
Hyper vitaminosis D: are we overprescribing vitamin D?
by: R Hemachandar, et al.
Published: (2014-01-01) -
The overprescribing of opioids: a public health approach to an epidemic of addiction
by: Sadia Iram, et al.
Published: (2023-05-01)